Summit Therapeutics plc Share Price London S.E.
Equities
GB00BN40HZ01
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.46B 3.08B 257B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.88% |
Latest transcript on Summit Therapeutics plc
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/20/11 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/19/01 |
Director of Finance/CFO | 46 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/19/01 |
Robert Booth
BRD | Director/Board Member | 70 | 28/22/28 |
Director of Finance/CFO | 46 | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |